Hematology & Blood Cancer Treatment
We treat leukemia, lymphoma, myeloma, and other blood disorders with chemotherapy, bone marrow evaluations, and advanced drug therapies. Patients receive integrated care and long-term monitoring for improved outcomes.
Frequently Asked Question's About Hematology
What are blood cancers, and which types are commonly treated?
Blood cancers are cancers that affect blood-forming tissues, bone marrow, or parts of the immune system. Common types include leukemia, lymphoma, and multiple myeloma, with each requiring a different treatment approach.
What symptoms can be associated with blood cancer?
Symptoms may include persistent tiredness, frequent infections, unexplained fever, unusual bruising or bleeding, swollen lymph nodes, night sweats, or unexplained weight loss. These symptoms can also occur with other conditions, so proper medical evaluation is important.
How are blood cancers diagnosed?
Diagnosis may involve blood tests, examination of blood cells, bone marrow evaluation, imaging, and other specialised tests depending on the suspected condition. These investigations help doctors determine the type of blood disorder or cancer and plan appropriate treatment.
What treatments are used for blood cancer?
Treatment depends on the specific blood cancer, its characteristics, and the patient's overall health. Depending on the condition, treatment may include chemotherapy, targeted medicines, immunotherapy, or other specialised therapies. NIVIK's Hematology & Blood Cancer service includes chemotherapy, bone marrow evaluations, and advanced drug therapies. (Nivik)
Why is regular monitoring important during blood cancer treatment?
Regular monitoring allows the medical team to assess how the disease is responding to treatment, track blood counts and other health indicators, and adjust the treatment plan when needed. Long-term follow-up may also be important after treatment. NIVIK provides integrated care and long-term monitoring for patients with blood cancers and blood disorders. (Nivik)
